Zykadia (ceritinib) — Medica
Peripheral T-Cell Lymphomas – Anaplastic Large Cell Lymphoma (ALK)-Positive
Initial criteria
- Patient is age ≥ 18 years
- Patient has anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL)
Approval duration
1 year